arrow_back Back to Insights
Documentation

Study Documentation Gaps That Lead to Inspection Findings

How unclear protocols, inconsistent documentation, and oversight gaps create avoidable regulatory risk.

Study Documentation Gaps That Lead to Inspection Findings

Documentation gaps are rarely the result of intentional malfeasance; they are almost always the product of systemic friction. When protocols are poorly written, case report forms (CRFs) are unintuitive, or electronic systems lack interoperability, site coordinators and investigators will inevitably create documentation errors.

The Butterfly Effect of Poor Documentation

A missing signature on a delegation log might seem trivial, but to an FDA investigator, it raises a profound question: "If this person wasn't authorized to conduct this assessment, is the resulting efficacy data valid?" A single documentation gap can cast a shadow of doubt over an entire dataset.

Sponsors must prioritize user-centric design in their clinical systems and protocols. By simplifying documentation requirements and ensuring absolute clarity in the protocol schedule of assessments, sponsors can drastically reduce the cognitive load on site staff, thereby eliminating the root cause of the most common FDA 483 observations.